ResearchPermissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline Exposure.
Aug 5, 2025Journal ArticlePonatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.Written by 1 Roon author & 10 others Via The American Heart Association Journals
ResearchDistinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis.
ResearchIdentifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.
Aug 15, 2024Journal ArticleEndothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.Written by 1 Roon author & 2 others Via The American Heart Association Journals
ResearchDifferential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.
ResearchPolyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.
ResearchFXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.